PharmaTher Holdings Ltd. (OTC:PHRRF – Get Rating) shot up 5.1% during trading on Wednesday . The stock traded as high as $0.11 and last traded at $0.11. 22,300 shares were traded during mid-day trading, a decline of 87% from the average session volume of 167,277 shares. The stock had previously closed at $0.10.
PharmaTher Trading Up 5.1 %
The stock's fifty day moving average price is $0.12 and its 200-day moving average price is $0.09.
PharmaTher Company Profile
(Get Rating)
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications.
Featured Stories
- Get a free copy of the StockNews.com research report on PharmaTher (PHRRF)
- Penny Stock Wag! Group Co. Has Solid Sell-Side Support
- Staples Stocks Get Lift From Conagra Results, New Highs In Sight
- SGH Bottomed, But Can It Reverse And Move Higher?
- Is Pinterest Showing Signs of an Improving Ad Market?
- At 3x Earnings, Avis Budget Is Worth Taking for a Spin
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.